Nomoto K, Tomita N, Miyake M, Xhu D B, LoGerfo P R, Weinstein I B
Columbia-Presbyterian Cancer Center, Columbia University Health Sciences, New York, NY, USA.
Jpn J Cancer Res. 1998 Dec;89(12):1257-66. doi: 10.1111/j.1349-7006.1998.tb00522.x.
By using a retrovirus-derived system we generated derivatives of the human colon adenocarcinoma cell line LS174T (ATCC CL 188) that stably overexpress a full-length cDNA encoding the beta 1 isoform of bovine phosphoinositides-specific phospholipase C (PI-PLC). This was confirmed by the elevated levels of catalytic activity to release phosphoinositides from phosphatidylinositol (PI-PLC) or phosphatidylinositol-bis-phosphate (PIP2-PLC), and the enhanced expressions of messenger RNA and protein. PI-PLC beta 1 overexpresser clones grew to form cell clumps floating in liquid medium, whereas the pMV7-introduced control clones displayed morphologic characteristics that were very similar to those of the parent LS174T cell line. Three individual PI-PLC beta 1 overexpresser cell lines displayed increased doubling time (18.0 h, 21.5 h, and 23.8 h) when compared with 4 individual pMV7-introduced control cell lines (13.1 h, 10.7 h, 12.9 h, and 9.3 h). Anchorage-independent growth ability in soft agar medium was dramatically suppressed by overexpression of PLC beta 1, and the ability of PLC-overproducer clones to form aggregates when cultured in liquid medium was dramatically enhanced when compared with that of pMV7-introduced control clones. Tumorigenicity of PLC beta 1-overproducers was much weaker than that of vector-transduced control clones. The spontaneous release of carcinoembryonic antigen from PLC beta 1-overproducer clones was much higher than that from pMV7 control clones. The ability of PLC beta 1-overproducer clones to form aggregates during suspension culture was much stronger than that of the control clones. These results provide the first evidence that elevated levels of endogenous PI-PLC beta 1 suppress tumor cell growth, but enhance the ability to form cell aggregates and to release carcinoembryonic antigen, an intercellular adhesion molecule.
通过使用逆转录病毒衍生系统,我们构建了人结肠腺癌细胞系LS174T(ATCC CL 188)的衍生物,这些衍生物稳定过表达编码牛磷酸肌醇特异性磷脂酶C(PI-PLC)β1同工型的全长cDNA。从磷脂酰肌醇(PI-PLC)或磷脂酰肌醇二磷酸(PIP2-PLC)释放磷酸肌醇的催化活性水平升高,以及信使RNA和蛋白质表达增强,证实了这一点。PI-PLC β1过表达克隆生长形成漂浮在液体培养基中的细胞团块,而导入pMV7的对照克隆表现出与亲本LS174T细胞系非常相似的形态特征。与4个导入pMV7的对照细胞系(13.1小时、10.7小时、12.9小时和9.3小时)相比,3个单独的PI-PLC β1过表达细胞系显示出加倍时间增加(18.0小时、21.5小时和23.8小时)。在软琼脂培养基中不依赖贴壁的生长能力因PLC β1的过表达而显著受到抑制,与导入pMV7的对照克隆相比,PLC过表达克隆在液体培养基中培养时形成聚集体的能力显著增强。PLC β1过表达细胞系的致瘤性比载体转导的对照克隆弱得多。PLC β1过表达克隆中癌胚抗原的自发释放比pMV7对照克隆高得多。PLC β1过表达克隆在悬浮培养期间形成聚集体的能力比对照克隆强得多。这些结果首次证明,内源性PI-PLC β1水平升高会抑制肿瘤细胞生长,但会增强形成细胞聚集体和释放细胞间粘附分子癌胚抗原的能力。